neuroClues: Biomarkers in a Blink

Introduction

neuroClues is an innovative AI-powered eye-tracking tool designed to assist health practitioners in diagnosing and monitoring neurological diseases. By leveraging eye movements as biomarkers, neuroClues aims to identify neurological conditions years before symptoms become apparent, offering a non-invasive, quick, and robust solution for clinical exams.

Key Features

• Enhanced Diagnosis: neuroClues provides sensitivity and specificity to aid in ruling out differential diagnoses.
• Objective Measurements: The tool offers precise tracking of disease progression and treatment efficacy.
• Intuitive Research Tool: With high spatial and temporal resolution, neuroClues supports both clinical and research applications.

Use Cases

neuroClues is particularly beneficial in the following scenarios:

• Early Diagnosis: Identifying neurological diseases before symptoms manifest.
• Patient Follow-Up: Monitoring disease progression and treatment effectiveness.
• Research Support: Facilitating studies on neurological conditions and potential treatments.

Testimonials

Several experts have praised neuroClues for its potential impact on neurology:

• "neuroClues will bring to the neurologist the scientific evidence developed across several decades." - Bertrand Gaymard, Neurologist
• "The seamless use of neuroClues will be a great help for both the research and the clinical practitioners." - Aasef Shaikh, Neurologist

Conclusion

neuroClues represents a significant advancement in the field of neurology, offering a powerful tool for early diagnosis and objective monitoring of neurological diseases. Its ease of use and robust scientific foundation make it a valuable asset for both practitioners and researchers alike.